Thyrocare Technologies Limited (BOM:539871)
India · Delayed Price · Currency is INR 403.30
+1.70 (0.42%)
At close: Feb 13, 2026
Thyrocare Technologies Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 7,923 | 6,874 | 5,719 | 5,267 | 5,889 | 4,946 |
Other Revenue | - | - | 0.1 | - | - | - |
| 7,923 | 6,874 | 5,719 | 5,267 | 5,889 | 4,946 | |
Revenue Growth (YoY) | 21.06% | 20.19% | 8.59% | -10.56% | 19.05% | 13.90% |
Cost of Revenue | 3,719 | 3,419 | 2,964 | 2,844 | 2,419 | 2,304 |
Gross Profit | 4,204 | 3,454 | 2,755 | 2,423 | 3,469 | 2,642 |
Selling, General & Admin | 212.2 | 212.2 | 208.9 | 120.5 | 83 | 65 |
Other Operating Expenses | 1,544 | 1,338 | 1,159 | 1,093 | 1,038 | 862.9 |
Operating Expenses | 2,340 | 2,102 | 1,838 | 1,601 | 1,459 | 1,231 |
Operating Income | 1,864 | 1,352 | 917.1 | 821.9 | 2,010 | 1,411 |
Interest Expense | -20 | -30.7 | -42 | -23.5 | -23.7 | -8.7 |
Interest & Investment Income | 51.2 | 51.2 | 27.1 | 13.8 | 7.1 | 7.9 |
Earnings From Equity Investments | 1.8 | -14.4 | 3.9 | 11.8 | -1.8 | -0.7 |
Currency Exchange Gain (Loss) | 1.5 | 1.5 | 0.1 | - | - | -1.4 |
Other Non Operating Income (Expenses) | 29.5 | 6.5 | 5.1 | 3.9 | 18 | 21.2 |
EBT Excluding Unusual Items | 1,928 | 1,366 | 911.3 | 827.9 | 2,010 | 1,430 |
Gain (Loss) on Sale of Investments | 88.1 | 88.1 | 57.8 | 53.7 | 52.2 | 36.8 |
Gain (Loss) on Sale of Assets | 0.3 | 0.3 | -9.3 | 4.3 | 215.2 | 58.4 |
Other Unusual Items | -61.6 | - | - | - | - | - |
Pretax Income | 1,955 | 1,454 | 959.8 | 885.9 | 2,277 | 1,525 |
Income Tax Expense | 599.2 | 546.9 | 264.9 | 242.3 | 515.8 | 393.2 |
Earnings From Continuing Operations | 1,356 | 907.5 | 694.9 | 643.6 | 1,761 | 1,132 |
Minority Interest in Earnings | 19.1 | 7.6 | 12.7 | 1.3 | - | - |
Net Income | 1,375 | 915.1 | 707.6 | 644.9 | 1,761 | 1,132 |
Net Income to Common | 1,375 | 915.1 | 707.6 | 644.9 | 1,761 | 1,132 |
Net Income Growth | 56.69% | 29.32% | 9.72% | -63.39% | 55.67% | 28.00% |
Shares Outstanding (Basic) | 157 | 159 | 159 | 159 | 159 | 159 |
Shares Outstanding (Diluted) | 157 | 159 | 159 | 159 | 159 | 159 |
Shares Change (YoY) | -1.87% | 0.13% | 0.06% | 0.05% | 0.06% | 0.07% |
EPS (Basic) | 8.76 | 5.76 | 4.46 | 4.06 | 11.10 | 7.14 |
EPS (Diluted) | 8.75 | 5.74 | 4.45 | 4.06 | 11.08 | 7.12 |
EPS Growth | 59.68% | 29.16% | 9.65% | -63.41% | 55.59% | 27.89% |
Free Cash Flow | - | 1,464 | 1,061 | 856.6 | 755.8 | 880.4 |
Free Cash Flow Per Share | - | 9.19 | 6.67 | 5.39 | 4.75 | 5.54 |
Dividend Per Share | - | 7.000 | 6.000 | 6.000 | 5.000 | 8.333 |
Dividend Growth | - | 16.67% | - | 20.00% | -40.00% | 399.99% |
Gross Margin | 53.06% | 50.26% | 48.17% | 46.00% | 58.92% | 53.41% |
Operating Margin | 23.53% | 19.67% | 16.04% | 15.61% | 34.14% | 28.53% |
Profit Margin | 17.35% | 13.31% | 12.37% | 12.25% | 29.91% | 22.88% |
Free Cash Flow Margin | - | 21.30% | 18.54% | 16.26% | 12.83% | 17.80% |
EBITDA | 2,386 | 1,815 | 1,301 | 1,136 | 2,292 | 1,662 |
EBITDA Margin | 30.12% | 26.40% | 22.75% | 21.56% | 38.93% | 33.60% |
D&A For EBITDA | 522.33 | 463 | 383.9 | 313.8 | 282.1 | 250.9 |
EBIT | 1,864 | 1,352 | 917.1 | 821.9 | 2,010 | 1,411 |
EBIT Margin | 23.53% | 19.67% | 16.04% | 15.61% | 34.14% | 28.53% |
Effective Tax Rate | 30.65% | 37.60% | 27.60% | 27.35% | 22.65% | 25.79% |
Revenue as Reported | 8,095 | 7,022 | 5,813 | 5,351 | 6,181 | 5,071 |
Advertising Expenses | - | 194.1 | 167.4 | 64.4 | 53 | 56.6 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.